Open AccessSusceptibility to Fluoroquinolones of <emph type="ital">Vibrio cholerae</emph> O1 Isolated From Diarrheal Patients in Zimbabwe
Author(s) -
M. Sirajul Islam
Publication year - 2009
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2009.1750
Subject(s) - vibrio cholerae , medicine , microbiology and biotechnology , diarrheal diseases , cholera , diarrhea , type (biology) , virology , bacteria , genetics , biology , ecology
Financial Disclosures: Dr Lyketsos reported having received grant support from the National Institute of Mental Health, the National Institute on Aging, the Associated Jewish Federation of Baltimore, the Weinberg Foundation, Forest, GlaxoSmithKline, Eisai, Pfizer, AstraZeneca, Lilly, Ortho-McNeil, Bristol-Myers, and Novartis; having served as a consultant or advisor for AstraZeneca, GlaxoSmithKline, Eisai, Novartis, Forest, Supernus, Adlyfe, Takeda, Wyeth, Lundbeck, Merz, and Lilly; and having received honoraria or travel support from Pfizer, Forest, GlaxoSmithKline, and Health Monitor. No other disclosures were reported.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom